Of relevance, expression levels of hepcidin and FPN1 govern disease outcome in breast cancer and decreased SCL40A1 gene expression is an independent predictor of reduced metastasis-free and disease-specific survival (161). The gene discussed is SLC40A1; the disease is breast cancer.